Immunohistochemical expression of p53, p63, c-myc, p21WAF1/cip1 and p27kiP1 proteins in urothelial bladder carcinoma: correlation with clinicopathological parameters

被引:0
作者
Grapsa, Dimitra [1 ]
Dokou, Anna [1 ]
Tsokanou-Kouli, Vassiliki [2 ]
Kaltsas, Serafim [1 ]
Dalakou, Eleftheria [1 ]
Trigidou, Rodoula [3 ]
Saif, Muhammad W. [4 ]
Politi, Ekaterini [2 ]
机构
[1] Sotiria Gen Hosp, Athens Sch Med, Dept Med 3, Oncol Unit, Athens 11527, Greece
[2] Arete Hosp, Dept Cytopathol, Athens, Greece
[3] Sotiria Gen Hosp, Dept Pathol, Athens 11527, Greece
[4] Tufts Med Ctr, Div Hematol Oncol, Boston, MA USA
来源
JOURNAL OF BUON | 2014年 / 19卷 / 04期
关键词
c-myc; cyclin-dependent kinase inhibitors; p53; p63; urinary bladder carcinoma; CANCER; PROGRESSION; BIOMARKERS; P21; PRB;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To reevaluate the expression levels of p53, p63, c-myc, p21(WAF1/cip1) and p27(kiP1) proteins and their potential association with standard clinicopathological parameters, including tumor stage and grade, in urothelial bladder carcinoma (UBC). Methods: Immunohistochemistry was performed in 100 transurethral resection specimens obtained from prospectively identified patients with primary UBC. Results: Overall, 26, 41 and 75% of the cases showed positive staining for p53, p63 and c-myc, respectively, while p21(WAF1/cip1) and p27(kip1) expression levels were altered in 75 and 88% of the cases, respectively. Positive staining for p53 was associated with increased tumor stage (pT2) (p=0.037), while altered expression of p27(kiP1) was strongly associated with male gender (p=0.009). Conclusion: The results of our study imply that p53 overexpression may be a useful marker of tumor invasion in UBC. In contrast, we failed to demonstrate any statistically significant correlation between the remaining markers evaluated and tumor stage or grade.
引用
收藏
页码:1121 / 1124
页数:4
相关论文
共 12 条
[11]   Loss of p63 expression is associated with tumor progression in bladder cancer [J].
Urist, MJ ;
Di Como, CJ ;
Lu, ML ;
Charytonowicz, E ;
Verbel, D ;
Crum, CP ;
Ince, TA ;
McKeon, FD ;
Cordon-Cardo, C .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) :1199-1206
[12]  
Visca P, 1999, CLIN CANCER RES, V5, P4111